Immune responses against the recombinant FimX and putative peptidyl-prolyl cis-trans isomerase from Bordetella pertussis

Download
2011
Yılmaz, Çiğdem
Whooping cough (pertussis) is a highly contagious respiratory infection caused by Bordetella pertussis. It becomes widespread among adolescent and adults as well as infants. Although availability of effective pertussis vaccines seems to decrease the incidence of the disease, B. pertussis circulation in population has not been eliminated. It is thought that the antigenic drifts in major protective antigens and continued circulation of B. pertussis strains will result in gradual loss of the efficacy of the current pertussis vaccines. Therefore, development of more effective acellular pertussis vaccines with conserved protective proteins is a convenient strategy to provide a better protection against whooping cough. In this study, immune responses against putative peptidyl-prolyl cis-trans isomerase (PPIase) which was shown to be immunogenic in B. pertussis for the first time by our immunoproteome group and FimX whose expression was found higher in our local Saadet strain were determined in mice. The genes encoding FimX and putative PPIase were amplified by PCR, cloned into pGEM®-T Easy vector and sequenced. The genes were then introduced into pET-28a (+) vector and they were expressed in Escherichia coli BL21(DE3) cells. The recombinant proteins were purified by His-tag affinity chromatography and dialyzed. After Western blot analyses, 20 µg and 80 µg recombinant FimX and 80 µg recombinant putative PPIase were used to immunize BALB/c mice (16-18 g) at day 0 and 21. The mice were challenged intranasally with 2.5 x 109 live B. pertussis Saadet cells. Before second immunization and challenge, the sera were collected to carry out ELISA for measurement of serum-specific IgG levels. According to ELISA results, IgG levels in the mice immunized with 20 µg and 80 µg recombinant FimX were found significantly higher than in control groups at both first and second vaccinations (p<0.01). On the other hand, immunization with 160 µg recombinant putative PPIase provided a significant increase in IgG level (p<0.05) only at second vaccination. The lungs of the mice were removed at day 2, 5, 8 after challenge and bacterial colonization was determined. No significant decrease in bacterial colonization was observed in the lungs of the mice immunized with 20 µg and 80 µg recombinant FimX and 80 µg recombinant putative PPIase with respect to control groups. After respiratory challenge and second immunization (at day 30) with 20 µg and 80 µg recombinant FimX, the spleens of the mice were removed and a spleen cell culture was obtained. Supernatants were collected after induction of the cells with the recombinant protein and cytokine ELISA was carried out to measure IFN-γ level. No significant difference was observed between control and vaccinated mice in terms of IFN-γ production.

Suggestions

Assessment of immune protective capacity of the recombinant iron-superoxide dismutase (fesod) from bordetella pertussis
Apak, Aycan; Özcengiz, Gülay; Department of Biology (2011)
Whooping cough (pertussis) is a highly contagious acute respiratory disease caused by the strict human pathogen Bordetella pertussis, a gram-negative coccobacillus. The worldwide mass-vaccination was started in 1940s and to date, a number of whole-cell (Pw) and acellular pertussis vaccine (Pa) formulations were developed. Yet the current vaccines are incapable of providing sustained, lifelong immunity and eliminating subclinical infections, which pose a threat especially for unimmunized infants as well as a...
Immunogenicity and protective efficacy of recombinant iron superoxide dismutase protein from Bordetella pertussis in mice models
Yilmaz, Cigdem; Apak, Aycan; Ozcengiz, Erkan; Özcengiz, Gülay (Wiley, 2016-11-01)
Whooping cough (pertussis) is a highly contagious respiratory infection caused by Bordetella pertussis. Although availability of effective pertussis vaccines reportedly decreases the incidence of the disease, B. pertussis circulation in populations has not been eliminated. Thus, it is necessary to find new protein candidates with greater immune protective capacities than the currently available acellular pertussis vaccines. In this study, iron superoxide dismutase (FeSOD) gene (sodB) was cloned, expressed i...
Towards whole cell immunoproteome and subproteomes of bordetella pertussis
Tefon, Burcu Emine; Özcengiz, Gülay; Department of Biology (2012)
Bordetella pertussis is a gram-negative, human pathogen and etiologic agent of whooping cough (pertussis), a highly contagious, acute respiratory illness. In this study, the analysis of whole immunproteome and subproteomes of this microorganism was performed. The soluble cytoplasmic proteomes of B. pertussis Tohama I strain and a local isolate Saadet were separated by 2DE. By Western blot analysis, we identified 25 immunogenic proteins of three categories. In the first group, there were well-known proteins ...
Investigation on immunoprotectivity of recombinant vaccine candidates glutamine-binding periplasmic protein and putative peptidoglycan-binding protein in mouse model
Çiçek, Mustafa; Özcengiz, Gülay; Özcengiz, Erkan; Department of Biotechnology (2014)
Bordetella pertussis is a gram negative coccobacillus that causes pertussis known as whooping cough. After mass-vaccination started in 1940s, incidence of the disease has decreased. However, B. pertussis circulation in population has not been prevented completely. Starting from the first vaccination, development of several vaccines have been performed. These whole cell (Pw) and acellular pertussis (Pa) vaccines are not completely effective in terms of sustained, lifelong immunity and thus failure in elimina...
A comprehensive analysis of Bordetella pertussis surface proteome and identification of new immunogenic proteins
Tefon, Burcu E.; Maass, Sandra; Ozcengiz, Erkan; Becher, Doerte; Hecker, Michael; Özcengiz, Gülay (2011-04-27)
Whooping cough, caused by the gram negative pathogen Bordetella pertussis, is a worldwide acute respiratory disease that predominantly involves infants. In the present study, surface proteins of B. pertussis Tohama I and Saadet strains were identified by using 2DE followed by MALDI-TOF-MS/MS analysis and also geLC-MS/MS. With these approaches it was possible to identify 45 and 226 proteins, respectively. When surface proteins of the strains were separated by 2DE and analyzed by Western blotting for their re...
Citation Formats
Ç. Yılmaz, “Immune responses against the recombinant FimX and putative peptidyl-prolyl cis-trans isomerase from Bordetella pertussis,” M.S. - Master of Science, Middle East Technical University, 2011.